Keyphrases
Early Treatment
100%
Treatment Toxicity
100%
High-dose Methylprednisolone
100%
Total Bilirubin
33%
Venous Disease
33%
Non-responders
33%
Liver Dysfunction
33%
Unknown Etiology
22%
Methylprednisolone
22%
Pretransplant
11%
Randomized Controlled Trial
11%
Response to Therapy
11%
Survivors
11%
Corticosteroids
11%
Cytokine Production
11%
Potent Inhibitor
11%
Weight Gain
11%
Serious Complications
11%
Days of Treatment
11%
Bilirubin
11%
Stem Cell Transplantation
11%
Transplant Patients
11%
Cytokine Activation
11%
Seattle Criteria
11%
Fatal Outcome
11%
Biochemistry, Genetics and Molecular Biology
Drug Megadose
100%
Methylprednisolone
100%
Bilirubin
27%
Cytokine
9%
Cytokine Production
9%
Stem Cell Transplantation
9%
Randomized Controlled Trial
9%
Bilirubin Blood Level
9%
Immunology and Microbiology
Drug Megadose
100%
Methylprednisolone
100%
Cytokine
9%
Stem Cell Transplantation
9%
Cytokine Production
9%
Bilirubin Blood Level
9%
Pharmacology, Toxicology and Pharmaceutical Science
Methylprednisolone
100%
Bilirubin
36%
Vein Occlusion
27%
Liver Dysfunction
27%
Cytokine
18%
Randomized Controlled Trial
9%
Fatality
9%